In this article, we will explore the fascinating world of Pridinol and everything that this topic/person/date has to offer us. From its impact on society to its relevance in the current context, we will thoroughly analyze each facet of Pridinol to provide the reader with a complete and enriching vision. Through data, analysis and expert opinions, we will take another step towards understanding this topic/person/date, inviting us to reflect on its importance and implications in our lives. Get ready to immerse yourself in the exciting universe of Pridinol!
Clinical data | |
---|---|
Trade names | Myopridin |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth, parenteral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.390 |
Chemical and physical data | |
Formula | C20H25NO |
Molar mass | 295.426 g·mol−1 |
| |
(what is this?) (verify) |
Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.
It was approved for medical use in the UK in May 2020.